KBL
Click for more information
0.00% 0.1¢ kbl mining limited

Ann: First Zinc Concentrate Produced at Mineral Hill, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. w27
    2,481 Posts.
    lightbulb Created with Sketch. 768
    clock Created with Sketch.
    04/12/14
    10:55
    Post #: 14406241
    Early days yet. I don't think we can expect perfection in the first few days of processing. This is a trial. They will now revert to processing copper/lead/gold ore and do some thinking about modifications necessary and probably have a few more trials while the stopes are developed. This is just prudent practice.
    KBL Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
NEWS Scoping study unveils promising economics for the Ngami Copper Project, with potential copper resources up to 166Mt — find out more about what makes this a game-changer
right-arrow Created with Sketch.
NEWS Oversubscribed share purchase plan successfully raises $2.3 million, with all applications accepted in full
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KBL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.